Clinical Trial Update: Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing) [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study of Conbercept for Diabetic Macular Edema (Sailing) is being conducted; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Conbercept (conbercept)

Snippet

Sponsor: Chengdu Kanghong Biotech Co., Ltd. | Conditions: Diabetic Macular Edema | Phase 3 | Status: UNKNOWN